CIK 0001285819 · Non-accelerated filer<br>Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 911663741
- Phone
- 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,114,339
- in 5 filings, $626K under 10b5-1 plans
Net −$2,114,339. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-19 | JACOBSEN MICHAEL A VP FINANCE AND CAO | Option exercise | +10,000 | $10.27 | $103K | 24,000 |
| 2021-02-19 | JACOBSEN MICHAEL A VP FINANCE AND CAO | Sale | −10,000 | $22.64 | $226K | 14,000 |
| 2021-02-19 | JACOBSEN MICHAEL A VP FINANCE AND CAO | Option exercise · Stock Option (right to buy) | −10,000 | 73,100 | ||
| 2021-02-12 | Hood Leroy E. MD PhD Director | Option exercise | +5,000 | $4.53 | $23K | 74,390 |
| 2021-02-12 | Hood Leroy E. MD PhD Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2021-02-10 | JACOBSEN MICHAEL A VP FINANCE AND CAO | Option exercise | +1,900 | $10.27 | $20K | 15,900 |
| 2021-02-10 | JACOBSEN MICHAEL A VP FINANCE AND CAO | Sale | −1,900 | $22.49 | $43K | 14,000 |
| 2021-01-20 | JACOBSEN MICHAEL A VP FINANCE AND CAO | Option exercise · Stock Option (right to buy) | −1,900 | 83,100 | ||
| 2021-01-20 | JACOBSEN MICHAEL A VP FINANCE AND CAO | Option exercise | +10,000 | $9.37 | $94K | 14,000 |
| 2021-01-20 | JACOBSEN MICHAEL A VP FINANCE AND CAO | Option exercise · Stock Option (right to buy) | −10,000 | $9.37 | $94K | 19,188 |
| 2021-01-19 | JACOBSEN MICHAEL A VP FINANCE AND CAO | Sale | −9,500 | $19.95 | $190K | 4,000 |
| 2021-01-13 | Cable Thomas J. Director | Option exercise | +5,000 | $4.53 | $23K | 40,067 |
| 2021-01-13 | Cable Thomas J. Director | Sale | −5,000 | $16.97 | $85K | 35,067 |
| 2021-01-13 | Cable Thomas J. Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2020-10-26 | Cancelmo Peter B VP, GEN. COUNSEL & CORP. SEC. | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-06-05 | Cable Thomas J. Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2020-06-05 | Demopulos Peter A MD Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2020-06-05 | Hood Leroy E. MD PhD Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 |
Page 9 of 9 · 178 trades